ENDEFR
Home › Sweden › Immedica Pharma AB

Immedica Pharma AB

Aktiebolag (AB) · Stockholm, Sweden · LEI 549300Q0QKHL3MF7FV02
LEI active

Summary

Immedica Pharma AB is registered in Sweden and entered in the “Companies Register (Bolagsverket)” under number 556835-6322. Its legal form is Aktiebolag (AB) – limited company (Sweden). According to GLEIF, its ultimate parent is Impilo Partners AB (Sweden). That group has 7 subsidiaries with LEIs in 2 countries, 6 of them in Sweden. The LEI was first issued on 10 May 2019 and the record was last updated on 30 Mar 2026; the next renewal is due by 12 May 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formAktiebolag (AB)
limited company (Sweden)
RegisterCompanies Register (Bolagsverket) · Register website
Registration number556835-6322
Registration authoritySwedish Companies Registration Office
JurisdictionSweden
Registered addressSolnavägen 3H, 113 63 Stockholm, Sweden
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)23 Dec 2010
LEI549300Q0QKHL3MF7FV02
LEI statusactive
LEI first issued10 May 2019
LEI record last updated30 Mar 2026
Next LEI renewal12 May 2027
Corroboration of the LEI recordfully corroborated

Group membership

Impilo Partners AB Sweden ultimate parent
Immedica Pharma AB this entity
View the whole group: 7 subsidiaries in 2 countries

Relationship to the parent

Ultimate parent
ParentImpilo Partners AB
Accounting period31 Dec 2024 to 30 Dec 2025
Evidencesupporting documents
Corroborationfully corroborated
Relationship start26 Sep 2022
Recorded at GLEIF since26 Sep 2022
Last updated30 Mar 2026
Record statuscurrent

Parent not reported to GLEIF

  • Direct parent: the parent has no LEI and has not consented to obtain one.

Other names

  • Medical Need Europe AB · previous name
  • Aktiebolaget Grundstenen 133647 · previous name

History

26 Sep 2022Registered address changed
26 Sep 2022Headquarters address changed